90 related articles for article (PubMed ID: 16732329)
21. Reduced expression of MYO18B, a candidate tumor-suppressor gene on chromosome arm 22q, in ovarian cancer.
Yanaihara N; Nishioka M; Kohno T; Otsuka A; Okamoto A; Ochiai K; Tanaka T; Yokota J
Int J Cancer; 2004 Oct; 112(1):150-4. PubMed ID: 15305387
[TBL] [Abstract][Full Text] [Related]
22. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer.
Bapat SA; Mali AM; Koppikar CB; Kurrey NK
Cancer Res; 2005 Apr; 65(8):3025-9. PubMed ID: 15833827
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic significance of cellular DNA content and AgNOR count in ovarian cystadenoma].
Lu XL; Yi WM; Wang LF
Ai Zheng; 2003 Jan; 22(1):62-5. PubMed ID: 12561439
[TBL] [Abstract][Full Text] [Related]
24. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Zhang C; Wang YE; Zhang P; Liu F; Sung CJ; Steinhoff MM; Quddus MR; Lawrence WD
Hum Pathol; 2010 Feb; 41(2):255-61. PubMed ID: 19896693
[TBL] [Abstract][Full Text] [Related]
25. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
[TBL] [Abstract][Full Text] [Related]
26. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
27. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
28. Identification of differential genes in ovarian cancer using representational difference analysis of cDNA.
Chen H; Wang M; Wang XY; Gao S; Wang J; Guan XM
Chin Med Sci J; 2005 Sep; 20(3):185-9. PubMed ID: 16261890
[TBL] [Abstract][Full Text] [Related]
29. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
30. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.
Benzeno S; Lu F; Guo M; Barbash O; Zhang F; Herman JG; Klein PS; Rustgi A; Diehl JA
Oncogene; 2006 Oct; 25(47):6291-303. PubMed ID: 16732330
[TBL] [Abstract][Full Text] [Related]
31. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
32. Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma.
Takai N; Miyazaki T; Nishida M; Nasu K; Miyakawa I
Int J Mol Med; 2002 Aug; 10(2):211-6. PubMed ID: 12119561
[TBL] [Abstract][Full Text] [Related]
33. Novel heteroplasmic frameshift and missense somatic mitochondrial DNA mutations in oral cancer of betel quid chewers.
Tan DJ; Chang J; Chen WL; Agress LJ; Yeh KT; Wang B; Wong LJ
Genes Chromosomes Cancer; 2003 Jun; 37(2):186-94. PubMed ID: 12696067
[TBL] [Abstract][Full Text] [Related]
34. Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy.
Kusumbe AP; Bapat SA
Cancer Res; 2009 Dec; 69(24):9245-53. PubMed ID: 19951996
[TBL] [Abstract][Full Text] [Related]
35. Establishment of human ovarian serous carcinomas cell lines in serum free media.
Pan Z; Hooley J; Smith DH; Young P; Roberts PE; Mather JP
Methods; 2012 Mar; 56(3):432-9. PubMed ID: 22445873
[TBL] [Abstract][Full Text] [Related]
36. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
Liu C; Zhao Y; Sun X
Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
[TBL] [Abstract][Full Text] [Related]
37. Association of decreased mitochondrial DNA content with ovarian cancer progression.
Wang Y; Liu VW; Xue WC; Cheung AN; Ngan HY
Br J Cancer; 2006 Oct; 95(8):1087-91. PubMed ID: 17047655
[TBL] [Abstract][Full Text] [Related]
38. Properties of internalization factors contributing to the uptake of extracellular DNA into tumor-initiating stem cells of mouse Krebs-2 cell line.
Dolgova EV; Potter EA; Proskurina AS; Minkevich AM; Chernych ER; Ostanin AA; Efremov YR; Bayborodin SI; Nikolin VP; Popova NA; Kolchanov NA; Bogachev SS
Stem Cell Res Ther; 2016 May; 7(1):76. PubMed ID: 27225522
[TBL] [Abstract][Full Text] [Related]
39. Age influences on the molecular presentation of tumours.
Li CH; Haider S; Boutros PC
Nat Commun; 2022 Jan; 13(1):208. PubMed ID: 35017538
[TBL] [Abstract][Full Text] [Related]
40. Genomic-scale gene expression profiling of normal and malignant immune cells.
Alizadeh AA; Staudt LM
Curr Opin Immunol; 2000 Apr; 12(2):219-25. PubMed ID: 10712950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]